LYB004
/ Luye Group
- LARVOL DELTA
Home
Next
Prev
1 to 6
Of
6
Go to page
1
October 31, 2025
A Phase Ⅱ, Randomized, Observer-blinded, Parallel-Controlled Clinical Trial to Assess the Immunogenicity and Safety of the Recombinant Zoster Vaccine, LYB004 in Adults Aged 40 Years and Older
(ChiCTR)
- P2 | N=840 | Not yet recruiting | Sponsor: Hunan Provincial Center for Disease Control and Prevention; Guangzhou Patronus Biotech Co., Ltd.
New P2 trial • Herpes Zoster • Varicella Zoster • CD40LG
March 25, 2025
Safety and Immunogenicity of the Recombinant Zoster Vaccine, LYB004 in Adults Aged 40 Years and Older
(clinicaltrials.gov)
- P1 | N=92 | Recruiting | Sponsor: Guangzhou Patronus Biotech Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • Herpes Zoster • Varicella Zoster • CD40LG
March 13, 2025
LYB004-CT-AUS-101: A Safety and Immunogenicity Trial of the Recombinant Zoster Vaccine （CHO Cell）, LYB004 in Adults Aged 50 to 70 Years
(clinicaltrials.gov)
- P1 | N=48 | Active, not recruiting | Sponsor: Guangzhou Patronus Biotech Co., Ltd. | Recruiting ➔ Active, not recruiting | Trial completion date: May 2025 ➔ Sep 2025 | Trial primary completion date: Feb 2025 ➔ Sep 2025
Enrollment closed • Trial completion date • Trial primary completion date • Herpes Zoster • Varicella Zoster
March 13, 2025
Safety and Immunogenicity of the Recombinant Zoster Vaccine, LYB004 in Adults Aged 40 Years and Older
(clinicaltrials.gov)
- P1 | N=92 | Not yet recruiting | Sponsor: Guangzhou Patronus Biotech Co., Ltd.
New P1 trial • Herpes Zoster • Varicella Zoster
May 30, 2024
LYB004-CT-AUS-101: A Safety and Immunogenicity Trial of the Recombinant Zoster Vaccine （CHO Cell）, LYB004 in Adults Aged 50 to 70 Years
(clinicaltrials.gov)
- P1 | N=48 | Recruiting | Sponsor: Guangzhou Patronus Biotech Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • Herpes Zoster • Varicella Zoster
March 28, 2024
A Safety and Immunogenicity Trial of the Recombinant Zoster Vaccine （CHO Cell）, LYB004 in Adults Aged 50 to 70 Years
(clinicaltrials.gov)
- P1 | N=48 | Not yet recruiting | Sponsor: Guangzhou Patronus Biotech Co., Ltd.
New P1 trial • Herpes Zoster • Varicella Zoster
1 to 6
Of
6
Go to page
1